RifaiN, WarnickGR. Lipids, lipoproteins, apolipoproteins and other cardiovascular risk factors. In: BurtisCA, AshwoodER, BrunsDE, (eds). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Philadelphia: Elsevier Saunders, 2006:903–982.
2.
FriedewaldWT, LevyRI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem1972;18:499–502.
3.
StoneNJ, RobinsonJG, LichtensteinAH, . ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol2014;63:2889–2934.
4.
NordestgaardBG, . Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut- points – a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J2016;25:1944–1958.
5.
LangstedA, FreibergJJ, NordestgaardBG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation2008;118:2047–2056.doi:10.1161/CIRCULATIONAHA.108.804146
6.
LangstedA, NordestgaardBG. Nonfasting lipid Profiles: The way of the future. Clin Chem2015;61:1123–5.doi:10.1373/clinchem.2015.243139
7.
SidhuD, NauglerC. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med2012;172:1707–1710.doi:10.1001/archinternmed.2012.3708
8.
MoraS, RifaiN, BuringJE, . Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation2008;118:993–1001.doi:10.1161/CIRCULATIONAHA.108.777334
9.
SteinerMJ, SkinnerAC, PerrinEM. Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study. Pediatrics2011;128:463–470.doi:10.1542/peds.2011-0844
10.
CuiY, BlumenthalRS, FlawsJA, . Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med2001;161:1413–1419.doi:10.1001/archinte.161.11.1413
11.
NishikuraT, KobaS, YokotaY, . Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease. J Atheroscler Thromb2014;21:755–767.doi:10.5551/jat.23465
12.
MoriyamaK, TakahashiE. Non-HDL cholesterol is a more superior predictor of small dense LDL cholesterol than LDL cholesterol in Japanese subjects with TG levels <400 mg/dl. J Atheroscler Thromb2016;23:1126–1137.doi:10.5551/jat.33985
